No abstract

The study below comprises prospective analysis of patterns of allergen-specific T-cell reactivity in a cohort of 23 children bled at regular intervals from 6-10 weeks to 2 years of age, together with cross sectional studies on panels of cord and adult blood samples. The results indicate reciprocal patterns of responses to dietary and inhalant allergens, the former being frequent in infancy but rare in adults, whereas the latter are preserved and expand between infancy and adulthood. These findings are consistent with a recently proposed model for the development of immunity to environmental allergens which involves allergen-driven T-cell "selection" during early life leading to deletion of food allergen-specific T-cells via the induction of specific anergy, with concomitant selection and ultimately expansion of mutually exclusive TH-1-like or TH-2-like reactivity to inhalant allergens via Immune Deviation mechanisms.

No abstract

No abstract

The cytology of compatible and interspecific incompatible pollinations has been followed in selected species of the genus Rhododendron (Ericaceae). Pollinated pistils were fixed, cleared, stained in decolourized aniline blue, and observed by epifluorescence microscopy. Ten different abnormalities of arrested pollen tube tips have been detected, including burst, tapered, swollen, coiled, spiralling, spiky and variable diameter syndromes. A series of five errors of callose deposition in incompatible tubes has also been defined. Six different regions in the pistil for expression of pollen tube arrest have been found, including the stigmatic exudate, the mucilage of the upper and lower style canal, the ovary loculus, the micropyle. There may also be abnormal behaviour after entry into the embryo sac. Both the site of pollen tube arrest within the pistil, and the error syndrome of tip growth and callose deposition anomalies, are characteristic of each interspecific cross. These results are discussed in relation to the genetic control of reproduction.

No abstract

Food insecurity, inadequate access to adequate food due to economic constraints, affects one in eight households. Food insecurity is a serious structural problem affecting health, but dedicated policy action has been limited. In this study, we analyzed causal stories in Canadian political discussion about household food insecurity in provincial and federal Hansard records over two decades. Specifically, we examined patterns of archetypes -dominant characterizations of individuals and populations who experience food insecurity -and how these were used to convey a collective consciousness about 'model' food-insecure persons or groups.Archetypes aligned only with selected evidence of populations actually experiencing food insecurity.

Molecular characterization of allergens by recombinant DNA technology has made rapid progress in the recent few years. In the present study we immunized mice with aluminum hydroxide-adsorbed purified recombinant major timothy grass pollen allergens (rPhl p 1, rPhl p 2, rPhl p 5), dog albumin, a major animal dander allergen, and proteins with low (β-lactoglobulin) or no (ribulose diphosphate carboxylase) allergenic potential in humans. Allergens that bind high levels of IgE in humans (Phl p 1, Phl p 5, dog albumin) induced high IgE and IgG1 levels in mice, whereas proteins with little or no allergenic activity in humans failed to induce significant IgE and IgG1 levels in mice. Continuous immunization for a period of 27 wk resulted in the production of mouse IgG1 Abs that recognized recombinant allergen fragments/epitopes defined by IgE Abs of allergic patients. As a consequence, allergen-specific mouse Abs strongly inhibited human IgE binding to the allergens and suppressed the allergen-induced histamine release from human basophils. In summary, our data indicate that 1) the allergenic potency of a protein may be related to its overall immunogenicity and 2) prolonged immunization with single purified recombinant allergens induces protective IgG Abs. The presented experimental in vivo/in vitro system allows the evaluation of Ag preparations (e.g., recombinant allergens) to be used for immunotherapy in humans.